Anand Mehra's Net Worth
$181 Million
Who is Anand Mehra?
Anand Mehra has an estimated net worth of $181 Million. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Merus N.V., Aclaris Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Spark Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Galera Therapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., aTYR PHARMA INC, Versartis, Inc., and ALIMERA SCIENCES INC.
SEC CIK
Anand Mehra's CIK is 0001590102
Past Insider Trading and Trends
2014 was Anand Mehra's most active year for acquiring shares with 26 total transactions. Anand Mehra's most active month to acquire stocks was the month of April. 2014 was Anand Mehra's most active year for disposing of shares, totalling 28 transactions. Anand Mehra's most active month to dispose stocks was the month of July. 2019 saw Anand Mehra paying a total of $20,640,850.35 for 5,801,604 shares, this is the most they've acquired in one year. In 2019 Anand Mehra cashed out on 29,421,329 shares for a total of $59,708,658.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.945
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.31% | -750.68K |
$1.39 | -$1,042,698.68 | 1.38M |
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +71.72% | 2.13M |
$8.00 | $6,005,464.00 | 5.09M |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HISTOGENICS CORP (OCGN) Snapshot price: $0.515
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.08M |
$10.86 |
—
| 2.08M |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -38.75% | -297.07K |
$18.61 | -$13,658,095.29 | 469.59K |
Apr 14 - Apr 15
| |||
Form 4
|
∞
| 1.7K |
—
|
—
| 1.7K |
Apr 10
| |||
Form 4
| -51.06% | -800.00K |
$26.00 | -$20,800,000.00 | 766.66K |
Nov 25
| |||
Form 4
| -39.15% | -1.01M |
$24.91 | -$24,208,330.17 | 1.57M |
Jul 9 - Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| -6.94% | -191.98K |
—
|
—
| 2.57M |
Jun 2
| |||
Form 4
| -10.48% | -323.93K |
$16.00 | -$5,182,912.00 | 2.77M |
May 22
| |||
Form 4
|
∞
| 3.09M |
$6.49 |
—
| 3.09M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +300.87% | 1.16M |
$15.00 |
—
| 1.54M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.73M |
$13.00 |
—
| 1.73M |
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||